Millions of Americans worry about the high costs of life-saving prescription drugs. That’s why 25 years ago, Congress created the 340B Drug Pricing Program to help hospitals expand access to prescription drugs and support essential services for our most vulnerable patients.

The program constitutes less than 3% of the more than $450 billion in U.S. annual drug purchases. Because it is funded by drug manufacturer discounts, not federal dollars, it doesn’t cost the government or taxpayers one penny – but it makes a big difference to patients.

We’re deeply disappointed in the Centers for Medicare & Medicaid Services’ recent decision to cut payments to hospitals participating in 340B that will put needed prescription drugs further out of reach, and dramatically threaten access to health care for many, including the uninsured, the elderly, those with chronic conditions and the disabled.

Contrary to the Administration’s claims, this policy change does nothing to address the stated goal of reducing the cost of pharmaceuticals, and would actually cause increases in some Medicare beneficiaries’ out-of-pocket costs.

We led the effort to circulate letters signed by a majority of both houses of Congress calling on the Administration to reconsider this policy and recognize the need for the 340B program to continue at full strength. CMS’ decision goes against the will of the Congress, and Congress must intervene to rein them in. We look forward to working with Congress to address this issue. Stay tuned for further updates.

The AHA will also be leading a coalition of other hospital groups and members to pursue litigation to prevent these draconian cuts to payments for 340B drugs from taking effect. We’ve heard from you, our members, how vital the 340B program is – and we’ll do whatever we can to defend it.

Please join our fight and contact your members of Congress and urge them to support 340B. This program must be protected so that hospitals can continue to provide quality care and services for the neediest patients.

Related News Articles

On Tuesday, the Census Bureau reported that “a third of Americans now show signs of clinical anxiety or depression” due to the COVID-19 pandemic. It’s also…
Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs…
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
The Government Accountability Office today named three new members to the Medicare Payment Advisory Commission through April 2023. They are: Wayne…
An annual report into death by several factors tied to mental health and wellbeing — otherwise referred to as “deaths of despair” — topped 150,000 in 2018. The…
State Medicaid programs are reporting an uptick in enrollment compared with their fiscal year 2020 projections, due in part to the COVID-19 pandemic. The…